Clinical needs assessment to inform development of a new assay to detect antimalarial drugs in patient samples: A case study
Point-of-care assays have greatly increased access to diagnostic information and improved healthcare outcomes globally, especially in the case of tropical diseases in rural settings. Increased recognition of the impact of these tools and increased funding, along with advances in technology have led...
Main Authors: | Erin S. Coonahan, Chanaki Amaratunga, Carole A. Long, Joel Tarning |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLOS Global Public Health |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449106/?tool=EBI |
Similar Items
-
An aptamer-based sensor for the detection of antimalarial drugs
by: Coonahan, E
Published: (2019) -
Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
by: Tran Dang Nguyen, et al.
Published: (2023-07-01) -
Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence "transmission blocking" assay.
by: Joël Lelièvre, et al.
Published: (2012-01-01) -
Clinical Pharmacology Of Antimalarial Drugs.
Published: (1989) -
Clinical pharmacokinetics of antimalarial drugs.
by: White, N
Published: (1985)